Cofertility raised $7.25 million in Series A funds, taking its total funding to date to $16 million. The startup is making egg freezing more accessible by tying it to egg donation — it offers one program in which women can pay to freeze their eggs and store them all for their own later use, and another one that allows women to freeze their eggs for free when they give half to a family who can’t otherwise conceive.
Bluebird Kids Health raised $31.5 million in Series A funds. The startup seeks to improve pediatric care access in underserved areas by building practices in these areas and accepting all insurance types.
This webinar will explore how a banking platform approach could be the resource for your company.
Getting would-be investors—and the right kind of investors—to notice and care about your company requires a robust strategy.
Providence spun out its fourth digital health startup: Praia Health, a platform designed to build stronger relationships with patients by personalizing their healthcare journeys and connecting them to relevant resources and services. The startup also announced the closing of a $20 million Series A funding round led by Frist Cressey Ventures.
Forta Health raised $55 million in Series A funding on Wednesday. The startup offers a platform to help family caregivers quickly access care to manage their loved ones' chronic conditions. Its first area of focus is autism spectrum disorder (ASD).
Ketryx raised $14 million in Series A funds. The startups sells a platform — designed around FDA regulations and quality standards — that automates much of the work required from medical device companies’ development and quality teams.
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
Bright Uro raised $23 million in Series A funds to help achieve FDA clearance for its urodynamics system and launch the product in the U.S. Should it be cleared, the system will become the first product on the market able perform urodynamic monitoring wirelessly and without a catheter, the company's CEO said.
Allara raised $10 million in a Series A funding round led by GV. The startup offers membership-based virtual services to treat women's chronic hormonal conditions, such as PCOS and endometriosis. CEO Rachel Blank — former executive at Ro and investor at General Catalyst — founded the company partly due to the difficulty she experienced arriving at her own PCOS diagnosis.
Bold, a Los Angeles-based company offering a healthy aging platform for older adults, closed a $17 million Series A funding round. The startup seeks to improve the health of Medicare Advantage beneficiaries through personalized exercise programs designed to prevent falls, decrease musculoskeletal pain and boost physical activity levels.
The startup intends to use the money to expand its sales team, enter new markets and increase the breadth of its product offering.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
The startup's product, which is also called Hero, sorts and dispenses medication, automates refills and offers audible and digital reminders.
Aphelion Capital led the round for the Chicago-based startup, whose solution focuses on improving communication and coordination in the operating room.
Circulation, a Boston-based startup focused on the non-emergency medical transportation space, said it has raised $10.5 million from investors such as Boston Children's Hospital, Humana and Intermountain Healthcare Innovation Fund.
Targeting the growth factors that influence cell proliferation and differentiation in disease is a pretty “well-trodden” field, but Cambridge biotech Scholar Rock purports to take a new spin on the concept. It’s announced a $20 million Series A financing round, and plans to use the funds to move its preclinical work into clinical drug development. Scholar Rock is […]
Bronchopulmonary dysplasia is a common condition among premature infants that require ventilation after birth. It causes inflammation and scarring in their delicate lungs, leading to serious complications at the earliest and most critical stages of a preemie’s development. Cincinnati-based Airway Therapeutics has raised $4.6 million in Series A financing for its new treatment, AT-100, that prevents BPD in preemies. The company has developed a […]